Improving the detection, analysis, and reporting of harms in medicines and devices: the 2019 4Es Forum

By |2020-01-20T14:27:18+00:00January 20th, 2020|Categories: Adverse effects - Effets indésirables, Approvals - Homologations, Clinical trials - Essais cliniques, Conflict of interest - Conflits d’intérêts, HPV - HPV/VPH|

From October 7 to 9, 2019, Re-Check’s Catherine Riva participated in the 4Es Forum Improving the detection, analysis and reporting of harms in medicines, a three-day workshop organized by the Centre for Evidence-Based Medicine (CEBM Oxford) and Uppsala Monitoring Center, the WHO Collaborating Centre for International Drug Monitoring. The meeting was held at the Ettore Majorana [...]

Health Analytics Asia published a long interview on Re-Check’s work and its methods and standards

By |2020-01-17T10:52:16+00:00January 17th, 2020|Categories: Uncategorized|

Re-Check joined the Global Investigative Journalism Conference 2019 (GIJC19) that took place 25-29 September 2019 in Hamburg (D) with two presentations by Serena Tinari: an half-day workshop organized by CFI, the French media development agency, and the panel Investigating Health and Medicine – Tips & Techniques (1). At GIJC19 Serena contributed also to the “Documentaries Track” [...]

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.

This Is A Custom Widget

This Sliding Bar can be switched on or off in theme options, and can take any widget you throw at it or even fill it with your custom HTML Code. Its perfect for grabbing the attention of your viewers. Choose between 1, 2, 3 or 4 columns, set the background color, widget divider color, activate transparency, a top border or fully disable it on desktop and mobile.
Go to Top